This podcast is brought to you by:
Casey Lynch, a serial entrepreneur, is changing the perception of what being a biotech CEO means today as her company, which recently went public, explores new avenues to address Alzheimer’s disease.
This podcast is brought to you by:
Casey Lynch, a serial entrepreneur, is changing the perception of what being a biotech CEO means today as her company, which recently went public, explores new avenues to address Alzheimer’s disease.